CA9 and neoplasm: Biomarkers such as HIF-1α, vascular endothelial growth factor, glucose transporter 1, and carbonic anhydrase IX are linked to hypoxia-driven tumor behaviors and may serve as indicators of disease aggressiveness and patient outcomes.